An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• SHP2 (Src homology 2 domain-containing protein tyrosine phosphatase) is a key regulator in multiple signaling pathways.
• Mutations in SHP2 are linked to Noonan syndrome and pediatric cancers, making wild-type SHP2 inhibition a potential cancer therapy strategy.

Purpose of the Study:

• To elucidate the poorly understood conformational transitions governing SHP2 activation and ligand binding.
• To provide mechanistic insights into SHP2 allosteric regulation for potential therapeutic targeting.

Main Methods:

• Utilized molecular simulations to investigate the allosteric mechanisms of SHP2 activation.
• Analyzed the role of the N-SH2 domain in SHP2 conformational changes and ligand interactions.
• Validated the proposed model using N-SH2 variants with altered activity and responsiveness.

Main Results:

• Identified a crucial allosteric interaction that stabilizes the N-SH2 domain in an activating conformation.
• Demonstrated that only ligands binding to this specific activating conformation effectively activate SHP2.
• Rationalized the activity of N-SH2 variants, confirming the model of SHP2 activation.

Conclusions:

• SHP2 activation is critically dependent on ligand-induced selection of a specific N-SH2 domain conformation.
• This study provides a mechanistic understanding of SHP2 regulation, paving the way for targeted therapeutic interventions.
• Findings may open new avenues for developing SHP2 inhibitors or activators for cancer treatment.